BRIEF-Boehringer Ingelheim Start Of Phase II Clinical Trial Evaluating Its Investigational Triple GLP-1/GIP/NPY2 Receptor Agonist, BI 3034701
Over 260 people wounded in latest US airstrikes on Iran, Health Ministry official says, without giving fatality figures